Alcresta Therapeutics
RELIZORB
Manufacturer:
Alcresta Therapeutics
Name:
RELIZORB
HCPCS Code Descriptor:
In-line cartridge containing digestive enzyme(s) for enteral feeding, each
Category:
B Code
HCPCS:
B4105
NDC(s):
62205-0000-20
Primary Type:
Enzyme Replacement Therapy
Generic/Specialty Status:
Single-Source
Route of Administration:
Route Not Applicable
Potential NDC Listing Errors:
Our team has identified potential listing errors/discrepancies with the following NDCs:
62205-0000-20
Please contact us regarding potential compendia errors/discrepancies
About:
RELIZORB is an Enzyme Replacement Therapy drug manufactured by Alcresta Therapeutics and administered via the Route Not Applicable route of administration. The B Code: B4105 is aligned to the drug RELIZORB.